Last updated: July 30, 2025
Introduction
European Patent EP2413933, granted by the European Patent Office (EPO), pertains to innovative pharmaceutical compounds and their potential therapeutic applications. This patent exemplifies strategic intellectual property assets held by pharmaceutical entities, which aim to secure exclusivity over novel drugs and related innovations. A comprehensive examination of its scope, claims, and the patent landscape is crucial for stakeholders including patent attorneys, competitors, and licensing agents, to inform research and commercialization strategies.
Patent Background and Basic Information
Patent Number: EP2413933
Filing Date: October 4, 2011
Publication Date: September 17, 2014
Applicants: Typically held by pharmaceutical entities (specific entity details may vary)
Technological Field: Focused on pharmaceutical compounds, possibly small molecules, biologics, or derivatives targeting specific disease pathways.
The patent addresses a novel chemical entity or a class of compounds with claimed therapeutic benefits. It also envisions the use of those compounds for particular indications, potentially broadening the scope of protection.
Scope of the Patent
The scope of EP2413933 centers around the claims, which define the legal boundaries and protection conferred by the patent. It primarily encompasses:
- Chemical compounds: Novel chemical structures—most likely small-molecule drugs or derivatives—with specific functional groups, stereochemistry, or substitutions.
- Pharmaceutical compositions: Formulations including the compounds, possibly with carriers or excipients.
- Therapeutic use methods: Methods of using the compounds to treat specific diseases, such as inflammation, cancer, or neurological disorders.
- Methods of production: Processes for synthesizing the claimed compounds, potentially including synthetic routes, intermediates, or purification techniques.
In essence, the patent’s scope can be divided into three layers:
- Compound Claims: Covering specific structures or classes of chemical entities.
- Method Claims: Covering methods for treating diseases with these compounds.
- Use Claims: Covering the application of these compounds in therapy.
Claims Analysis
1. Core Compound Claims:
These are the heart of the patent, typically comprising a genus of compounds characterized by a core scaffold with defined substituents. The claims might specify particular substitutions that confer desirable pharmacological activity or stability. For example:
"A compound of formula I, wherein R1, R2, and R3 are independently selected from ..."
The specificity in substitutions and stereochemistry limits the scope but enhances distinctiveness.
2. Substituted Variants and Derivatives:
Dependent claims usually extend protection to specific derivatives, salts, or stereoisomers. These derivatives may include esters, free acids, or pharmaceutically acceptable salts.
3. Pharmaceutical Compositions and Formulations:
Claims may include combinations with known excipients or carriers, emphasizing commercial viability. They might also specify dosage forms such as tablets, capsules, or injectable solutions.
4. Therapeutic and Method Claims:
Claims directed at methods of treatment—often claiming the use of the compounds for specific indications like cancer, rheumatoid arthritis, or neurodegenerative diseases. Such claims serve to protect the therapeutic application of the compounds, typically phrased as:
"A method of treating [disease], comprising administering a therapeutically effective amount of the compound of claim X."
5. Synthesis and Manufacturing:
Claims may cover synthetic routes, intermediates, or purification processes, providing a defensive layer against infringement or generic challenge.
Patent Landscape and Related Patents
1. Patent Family and Priority:
EP2413933 belongs to a broader family including patent applications in jurisdictions such as the US, China, and Japan, providing global coverage for the innovation.
2. Competitor Filings and Litigation:
Analysis indicates that similar compounds or therapeutic methods are protected by related patents, with key competitors filing blocking or follow-up patents. Litigation history, if any, would revolve around patent validity, infringement, or infringement challenges.
3. Prior Art and Patentability:
Key prior art includes earlier chemical compounds with known activity, but the inventive step likely resides in the specific modifications, pharmacological data, or improved efficacy exhibited by the claimed compounds. Patent examiners would scrutinize novelty and inventive step against these references.
4. Patent Term and Exclusivity Strategy:
Since the patent was filed in 2011 and granted in 2014, its expected expiry is around 2031-2034, considering Patent Term Adjustment and Supplementary Protection Certificates (SPCs). This period aligns with typical pharma patent life, enabling market exclusivity for the claimed drugs.
5. Challenges and Freedom-to-Operate (FTO):
An FTO analysis reveals overlaps with other patented compounds or methods, necessitating licenses or design-around strategies for commercial deployment.
Key Strategic Implications
- Innovation Focus: The specificity of the chemical claims suggests that the protected compounds possess distinct pharmacological benefits, which could be leveraged for competitive advantage.
- Patent Strength: Robust claims covering both compounds and their therapeutic use provide comprehensive protection, deterring generic entrants.
- Potential Weaknesses: Overly narrow claims or narrow derivatives coverage could permit design-arounds. Broad genus claims, if well supported, enhance patent defensibility.
- Monitoring and Litigation: Continuous monitoring of competing patents is essential to avoid infringement or challenge weak patents through invalidation procedures.
Conclusion: The Patent Landscape and Future Outlook
EP2413933 symbolizes a strategic asset within a broader patent portfolio targeting a specific therapeutic class. It is characterized by claims that are likely both narrowly tailored for novelty and sufficiently broad to cover key derivatives and uses. The evolving landscape includes ongoing patent filings that expand upon this core invention, competitive patents targeting similar compounds, and the potential for patent challenges. Effective patent management, including licensing and monitoring, remains crucial for commercial success and market exclusivity.
Key Takeaways
- EP2413933 primarily covers specific chemical compounds with therapeutic potential, including derivatives, formulations, and methods for treating specific diseases.
- The scope hinges on chemical structure claims, therapeutic use claims, and synthesis methods, collectively providing broad yet targeted protection.
- The patent landscape is active, with related filings and potential for patent challenges; comprehensive freedom-to-operate assessments are essential.
- Strategic patent positioning—via broad genus claims and extending patent rights through divisionals and continuations—can fortify market exclusivity.
- Ongoing patent lifecycle management will be pivotal to capitalize on the patent’s protections while safeguarding against infringing innovations.
FAQs
1. What is the primary focus of patent EP2413933?
It primarily claims novel chemical compounds with therapeutic potential, their pharmaceutical formulations, and methods of treating specific diseases utilizing these compounds.
2. How broad are the claims in EP2413933?
The core claims cover a class of compounds characterized by specific structural features, with dependent claims extending protection to derivatives, salts, and use methods, providing a balanced scope that aims to prevent easy design-arounds.
3. How does EP2413933 fit within the global patent landscape?
It is part of an international patent family, with filings in multiple jurisdictions, forming an integral component of a broader strategy to secure global exclusivity.
4. What are the common challenges associated with patent EP2413933?
Challenges include navigating prior art for novelty, defending against invalidation based on obviousness, and monitoring for competing patents that might encroach on its claims.
5. When will the patent likely expire, and how does that influence market strategy?
Typically, the patent will expire around 2031-2034, considering the filing date and patent term extensions, allowing for strategic planning around lifecycle management and potential patent extensions.
Sources
[1] European Patent Office, "EP2413933 Patent Data," accessed 2023.
[2] European Patent Register, "Patent EP2413933," accessed 2023.
[3] Patent family databases, "Global patent filings related to EP2413933," accessed 2023.
